Navigation Links
WellGen, Inc. Launches Te Ame(TM) Nutritional Supplements With Proven Health Benefits of Proprietary Black Tea Extract

Natural Compound Enhances Exercise Recovery and Stress Management, Supports Natural Immune Function and Joint Health

NORTH BRUNSWICK, N.J., May 13 /PRNewswire/ -- WellGen, Inc., a life science company at the crossroads of food and pharmaceuticals, today announced the launch of its first consumer products, a line of nutritional supplements under the brand name Te Ame. The Te Ame(TM) line will initially be available in four different formulations, reflecting WellGen's research into a range of health and wellness benefits in the areas of exercise recovery, immunity, joint health and stress management.


Te Ame contains WellGen's proprietary natural compound, a unique black tea extract enriched for theaflavins. These natural compounds have demonstrated health benefits and are presented in significantly greater concentrations than available from brewed tea.

"This exciting product range is our first consumer offering and comes from years of research in top caliber laboratories," says Patricia Lucas-Schnarre, who is principally responsible for the commercialization of this healthcare advance. "For some time we've believed in the benefits of black tea. We now have a unique extract that scientifically captures these benefits. The best thing about Te Ame is that I can get these benefits without overloading my body with caffeine. As much as I love tea, I cannot drink over 20 cups a day."

WellGen's scientific program is based on a specialized knowledge of nutrigenomics, and studies the impact of proprietary natural compounds at the gene level. WellGen evaluates the effectiveness of its natural compounds in clinical studies to determine their impact on health and wellness. The studies on WellGen's proprietary black tea extract were conducted in WellGen's laboratories at the Commercialization Center for Innovative Technologies in North Brunswick, New Jersey, in the Human Performance Laboratory at Rutgers University, and at university and private research centers across the country.

Dr. Nancy Rawson, Chief Scientific Officer of WellGen, said, "Our research programs are teaching us a great deal about how foods influence health at the very basic level of our genes. With that expertise, WellGen's talented and dedicated scientists have worked hard to discover the fundamental health benefits that can be derived from compounds occurring naturally in black tea. Although you can get black tea anywhere, this proprietary ingredient has been demonstrated to be effective in clinical studies.

"As scientists, seeing these discoveries translated into Te Ame products with real health benefits is incredibly rewarding and exciting," she said.

Te Ame(TM) products will be sold online at The web site provides additional product description and more information about Te Ame. It also invites consumers to be part of the Te Ame community by posting their own comments, reading blogs about Te Ame written by the company's scientific and product development professionals, and through other social networking features.

Te Ame is the only brand of nutritional supplements that provides such a range of health and wellness benefits from black tea extract. Equally important, the raw materials in every batch are rigorously tested to meet stringent criteria for both chemical and bioactivity standards. The brand Te Ame(TM) is targeted to adults, and especially to women, who face many different wellness challenges. Te Ame(TM) Joint Care contains WellGen(R) theaflavin-enriched black tea extract which works in less than a week and also contains glucosamine. Clinical tests demonstrated that Te Ame(TM) Active Body soothes muscles after exercise. Te Ame(TM) Immune Defense supports the body's natural immunity. Te Ame(TM) Stress Manager is scientifically formulated to improve the body's response to stress.

To purchase Te Ame(TM) products online or to engage in the Te Ame(TM) conversations, please go to

About WellGen.

WellGen, Inc., based in North Brunswick, N.J., is a life science company at the crossroads of foods and pharmaceuticals. Using the science of nutrigenomics, the company has developed Alignomx(TM), a proprietary bioinformatics model that uses gene expression data to determine optimal therapeutic niches for WellGen's pipeline of proprietary natural products. Through its in-house expertise in nutrigenomics and natural product chemistry, WellGen is developing proprietary medical foods and has additionally identified several opportunities in the functional food and beverage and dietary supplement markets. Please visit our website at for more information.

SOURCE WellGen, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Dr. Roddy Carter Named President and Chief Executive Officer of WellGen, Inc.
2. WellGen, Inc. Names Robert M. Hellauer as Chief Financial Officer
3. WellGen, Inc. Names Nancy E. Rawson, Ph.D., Chief Scientific Officer
4. Amnis Launches New ImageStreamX Imaging Flow Cytometer
5. Xconomy Launches XSITE 2009; First Annual Xconomy Summit on Innovation, Technology, and Entrepreneurship at Boston University
6. Cyprotex Launches Cloe(R) Gateway, its Secure web Portal for Access to Cyprotex Services Including an Enhanced Version of Cloe(R) PK.
7. Tepha Partner Launches Novel Monofilament Absorbable Suture Utilizing Tephas Proprietary Biomaterial
8. Elsevier Launches Ten New eBook Specialty Collections on MD Consult
9. Histogen Aesthetics Launches ReGenica Rejuvenation System
10. AMG Launches EVOS fl, an 'Evolutionary' Fluorescence Microscope Based on Innovative EVOS Platform
11. GenVault Corporation Launches its Latest Centralized and Standardized Software Solution for Biobanking and Biological Sample Management, GenConnect 3.2
Post Your Comments:
(Date:6/24/2016)... ... ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical journal ... Their findings are the subject of a new article on the Surviving Mesothelioma website. ... the blood, lung fluid or tissue of mesothelioma patients that can help point doctors ...
(Date:6/23/2016)... , June 23, 2016   Boston Biomedical ... novel compounds designed to target cancer stemness pathways, ... been granted Orphan Drug Designation from the U.S. ... of gastric cancer, including gastroesophageal junction (GEJ) cancer. ... designed to inhibit cancer stemness pathways by targeting ...
(Date:6/23/2016)... , June 23, 2016 Houston Methodist ... the Cy-Fair Sports Association to serve as their ... agreement, Houston Methodist Willowbrook will provide sponsorship support, ... connectivity with association coaches, volunteers, athletes and families. ... the Cy-Fair Sports Association and to bring Houston ...
(Date:6/23/2016)... June, 23, 2016  The Biodesign Challenge (BDC), a ... ways to harness living systems and biotechnology, announced its ... in New York City . ... students, showcased projects at MoMA,s Celeste Bartos Theater during ... , MoMA,s senior curator of architecture and design, and ...
Breaking Biology Technology:
(Date:3/23/2016)... , March 23, 2016 ... Interesse erhöhter Sicherheit Gesichts- und Stimmerkennung mit ... Inc. (NASDAQ: MESG ), ein ... dass das Unternehmen mit SpeechPro zusammenarbeitet, um ... der Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, im ...
(Date:3/22/2016)... and SANDY, Utah , ... which operates the highest sample volume laboratory in ... Genomics and UNIConnect, leaders in clinical sequencing informatics and ... launch of a project to establish the informatics infrastructure ... NSO has been contracted by the Ontario ...
(Date:3/18/2016)... -- --> --> Competitive ... Unmanned Vehicles, Physical infrastructure and Perimeter Surveillance & Detection Systems ... security market and the continuing migration crisis in the ... has led visiongain to publish this unique report, which ... defence & security companies in the border security market ...
Breaking Biology News(10 mins):